Loading…

Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway

The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensit...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2016-06, Vol.474 (3), p.612-619
Main Authors: Xie, Jie, Tao, Zhong-Hua, Zhao, Jiang, Li, Ting, Wu, Zheng-Hua, Zhang, Jin-Feng, Zhang, Jian, Hu, Xi-Chun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393
cites cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393
container_end_page 619
container_issue 3
container_start_page 612
container_title Biochemical and biophysical research communications
container_volume 474
creator Xie, Jie
Tao, Zhong-Hua
Zhao, Jiang
Li, Ting
Wu, Zheng-Hua
Zhang, Jin-Feng
Zhang, Jian
Hu, Xi-Chun
description The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored. •GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.
doi_str_mv 10.1016/j.bbrc.2016.03.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790461653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X16303151</els_id><sourcerecordid>1790461653</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhi0EYsvCC3BAPi6HZMdOmjQSl9UKCmIlEFokbpZjT7ZTJXaxnaK-0D7numrhyGnm8M8388_P2FsBpQDRXG_Lvg-mlLkvoSoB5DO2ENBBIQXUz9kCAJpCduLXBXsV4xZAiLrpXrIL2YKQEroFe1yPs_ERecCHedQJLd8Fn5Acb1f8av3je7t6z8ltqKcUud75XfKRcucs1ymhS-TmhJGbDU4Z5CIl2lM6cD_wB5wMJd2Tw8zgfUAdEzfaGQzc4DjyPWl-8_X-eqLkzcY7G0iP5zWJDN_ptPmjD6_Zi0GPEd-c6yX7-enj_e3n4u7b-svtzV1hqmWTimwr-zKtHHopJDZay7bCCmzdiRoF2Krp7NAY2_a6bSrRQYew0svW9HLVV111ya5O3PyE3zPGpCaKx0O1Qz9HJdoO6kY0yypL5Ulqgo8x4KB2gSYdDkqAOuajtuqYjzrmo6BSOZ889O7Mn_sJ7b-Rv4FkwYeTALPLPWFQ0RDmf1kKaJKynv7HfwIW6aPT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790461653</pqid></control><display><type>article</type><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><source>ScienceDirect Journals</source><creator>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</creator><creatorcontrib>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</creatorcontrib><description>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored. •GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2016.03.002</identifier><identifier>PMID: 27012209</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antimetabolites, Antineoplastic - administration &amp; dosage ; Apoptosis ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Deoxycytidine - administration &amp; dosage ; Deoxycytidine - analogs &amp; derivatives ; Dose-Response Relationship, Drug ; Gemcitabine resistance ; GRP78 ; Heat-Shock Proteins - metabolism ; Humans ; MCF-7 Cells ; Mitochondria - drug effects ; Mitochondria - metabolism ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction - drug effects</subject><ispartof>Biochemical and biophysical research communications, 2016-06, Vol.474 (3), p.612-619</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</citedby><cites>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27012209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Jie</creatorcontrib><creatorcontrib>Tao, Zhong-Hua</creatorcontrib><creatorcontrib>Zhao, Jiang</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wu, Zheng-Hua</creatorcontrib><creatorcontrib>Zhang, Jin-Feng</creatorcontrib><creatorcontrib>Zhang, Jian</creatorcontrib><creatorcontrib>Hu, Xi-Chun</creatorcontrib><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored. •GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</description><subject>Antimetabolites, Antineoplastic - administration &amp; dosage</subject><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Deoxycytidine - administration &amp; dosage</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gemcitabine resistance</subject><subject>GRP78</subject><subject>Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>MCF-7 Cells</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction - drug effects</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kcGO0zAQhi0EYsvCC3BAPi6HZMdOmjQSl9UKCmIlEFokbpZjT7ZTJXaxnaK-0D7numrhyGnm8M8388_P2FsBpQDRXG_Lvg-mlLkvoSoB5DO2ENBBIQXUz9kCAJpCduLXBXsV4xZAiLrpXrIL2YKQEroFe1yPs_ERecCHedQJLd8Fn5Acb1f8av3je7t6z8ltqKcUud75XfKRcucs1ymhS-TmhJGbDU4Z5CIl2lM6cD_wB5wMJd2Tw8zgfUAdEzfaGQzc4DjyPWl-8_X-eqLkzcY7G0iP5zWJDN_ptPmjD6_Zi0GPEd-c6yX7-enj_e3n4u7b-svtzV1hqmWTimwr-zKtHHopJDZay7bCCmzdiRoF2Krp7NAY2_a6bSrRQYew0svW9HLVV111ya5O3PyE3zPGpCaKx0O1Qz9HJdoO6kY0yypL5Ulqgo8x4KB2gSYdDkqAOuajtuqYjzrmo6BSOZ889O7Mn_sJ7b-Rv4FkwYeTALPLPWFQ0RDmf1kKaJKynv7HfwIW6aPT</recordid><startdate>20160603</startdate><enddate>20160603</enddate><creator>Xie, Jie</creator><creator>Tao, Zhong-Hua</creator><creator>Zhao, Jiang</creator><creator>Li, Ting</creator><creator>Wu, Zheng-Hua</creator><creator>Zhang, Jin-Feng</creator><creator>Zhang, Jian</creator><creator>Hu, Xi-Chun</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160603</creationdate><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><author>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antimetabolites, Antineoplastic - administration &amp; dosage</topic><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Deoxycytidine - administration &amp; dosage</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gemcitabine resistance</topic><topic>GRP78</topic><topic>Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>MCF-7 Cells</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Jie</creatorcontrib><creatorcontrib>Tao, Zhong-Hua</creatorcontrib><creatorcontrib>Zhao, Jiang</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wu, Zheng-Hua</creatorcontrib><creatorcontrib>Zhang, Jin-Feng</creatorcontrib><creatorcontrib>Zhang, Jian</creatorcontrib><creatorcontrib>Hu, Xi-Chun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Jie</au><au>Tao, Zhong-Hua</au><au>Zhao, Jiang</au><au>Li, Ting</au><au>Wu, Zheng-Hua</au><au>Zhang, Jin-Feng</au><au>Zhang, Jian</au><au>Hu, Xi-Chun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2016-06-03</date><risdate>2016</risdate><volume>474</volume><issue>3</issue><spage>612</spage><epage>619</epage><pages>612-619</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored. •GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27012209</pmid><doi>10.1016/j.bbrc.2016.03.002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2016-06, Vol.474 (3), p.612-619
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_1790461653
source ScienceDirect Journals
subjects Antimetabolites, Antineoplastic - administration & dosage
Apoptosis
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Deoxycytidine - administration & dosage
Deoxycytidine - analogs & derivatives
Dose-Response Relationship, Drug
Gemcitabine resistance
GRP78
Heat-Shock Proteins - metabolism
Humans
MCF-7 Cells
Mitochondria - drug effects
Mitochondria - metabolism
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction - drug effects
title Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A23%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20regulated%20protein%2078%20(GRP78)%20inhibits%20apoptosis%20and%20attentinutes%20chemosensitivity%20of%20gemcitabine%20in%20breast%20cancer%20cell%20via%20AKT/mitochondrial%20apoptotic%20pathway&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Xie,%20Jie&rft.date=2016-06-03&rft.volume=474&rft.issue=3&rft.spage=612&rft.epage=619&rft.pages=612-619&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2016.03.002&rft_dat=%3Cproquest_cross%3E1790461653%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1790461653&rft_id=info:pmid/27012209&rfr_iscdi=true